Common Stock, Shares, Outstanding of Transcode Therapeutics, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Transcode Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Transcode Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 833,683, a 95% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Transcode Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 833,683 -16,431,975 -95% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 833,683 -6,431,975 -89% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 23,341,336 +17,533,283 +302% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 36,753 +17,739 +93% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 17,265,658 +6,577,934 +62% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 7,265,658 +5,314,984 +272% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 5,808,053 -10,015,481 -63% 31 Mar 2024 10-Q 15 May 2024 2023 Q3
Q4 2023 19,014 +2,792 +17% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 10,687,724 -2,289,510 -18% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 1,950,674 -11,026,560 -85% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 15,823,534 +2,846,300 +22% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 16,222 -12,888,352 -100% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 12,977,234 +72,660 +0.56% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 12,977,234 +8,341,018 +180% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 12,977,234 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 12,904,574 +8,268,358 +178% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 12,904,574 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 4,636,216 30 Jun 2021 10-Q 23 Aug 2021 2021 Q2
Q4 2020 4,636,216 31 Dec 2020 10-K 31 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.